Total Funding
46
7
Total FundingSeries A raised
Growth Score 46 in past quarter
1 pts
Heat Score 7 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
64438
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
- Theonie Anastassiadis: Founding President
- Noubar Afeyan: Co-Founder and ChairmanPast Role: Tessera Therapeutics, Co-Founder & Board Member
About the Company
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.